Mabion

Polish, public, clinical-stage, biotech company developing biosimilar monoclonal antibodies for oncology treatment

placeKonstantynow Lodzki, Lodz Voivodeship, Poland calendar_todayFounded 2007 groups268 employees language mabion.eu

Innovation

2 patent families — focus: Human necessities; filing pace steady. Cited 4 times.

YearFilings
20231
20241

Social engagement

Social engagement: 11.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Private equity150%

Recent activity

24 Jun 2026
Event
Company Presentation at BIO International Convention 2026
23 Jun 2026
Event
BIO International Convention 2026
19 Jun 2026
Partnership
Novavax
Coming soon